Illumina, Nvidia team to use AI in foundation models
- Illumina will collaborate with Nvidia to analyze multiomic data for clinical research and drug discovery, as announced on Monday.
- The partnership aims to provide researchers with advanced tools to apply generative AI in multiomic research, which includes genomics, transcriptomics, and epigenetics.
- Nvidia and Illumina will work together on Illumina's connected analytics platform to enhance multiomics data analysis and develop new biology foundation models.
- Illumina's CEO Jacob Thaysen highlighted the collaboration's role in the company's growth strategy during a presentation at the J.P. Morgan Chase Health Care Conference.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage